Literature DB >> 11803071

Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain.

Sérgio Souza da Cunha1, Laura C Rodrigues, Maurício L Barreto, Inês Dourado.   

Abstract

Data from routine surveillance during two mass immunisation campaigns (MIC) with Measles-mumps-rubella (MMR)vaccine using Leningrad-Zagreb mumps strain in two states in Brazil were analysed to estimate the risk of vaccine-related meningitis and mumps. Increase in the incidence of the two diseases was observed in both states, 3 weeks after the vaccination campaigns. The estimated number of doses applied per one case of vaccine-related meningitis ranged from 6199 (95% CI: 4854-8058) to 19,247 (95% CI: 12,648-29,513) depending on the diagnostic criteria used and state. It was 300 doses (95% CI: 286-317) for each case of mumps. The implications for vaccination policy are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11803071     DOI: 10.1016/s0264-410x(01)00438-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety.

Authors:  Peter I Folb; Ewa Bernatowska; Robert Chen; John Clemens; Alex N O Dodoo; Susan S Ellenberg; C Patrick Farrington; T Jacob John; Paul-Henri Lambert; Noni E Macdonald; Elizabeth Miller; David Salisbury; Heinz-J Schmitt; Claire-Anne Siegrist; Omala Wimalaratne
Journal:  Am J Public Health       Date:  2004-11       Impact factor: 9.308

Review 2.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 3.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

Review 4.  Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella.

Authors:  Keri Wellington; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Knowledge synthesis of benefits and adverse effects of measles vaccination: the Lasbela balance sheet.

Authors:  Robert J Ledogar; John Fleming; Neil Andersson
Journal:  BMC Int Health Hum Rights       Date:  2009-10-14

6.  Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination.

Authors:  Silvia Perez-Vilar; Daniel Weibel; Miriam Sturkenboom; Steven Black; Christine Maure; Jose Luis Castro; Pamela Bravo-Alcántara; Caitlin N Dodd; Silvana A Romio; Maria de Ridder; Swabra Nakato; Helvert Felipe Molina-León; Varalakshmi Elango; Patrick L F Zuber
Journal:  Vaccine       Date:  2017-05-27       Impact factor: 3.641

7.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

8.  In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccine.

Authors:  Sarah M Connaughton; Jun X Wheeler; Eva Vitková; Philip Minor; Silke Schepelmann
Journal:  Vaccine       Date:  2015-07-15       Impact factor: 3.641

9.  Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial.

Authors:  Ashwani Sood; Monjori Mitra; Himanshu Arvind Joshi; Uma Siddhartha Nayak; Prashanth Siddaiah; T Ramesh Babu; Samarendra Mahapatro; Jayesh Sanmukhani; Gaurav Gupta; Ravindra Mittal; Reinhard Glueck
Journal:  Hum Vaccin Immunother       Date:  2017-03-31       Impact factor: 3.452

10.  Immune response to the mumps component of the MMR vaccine in the routine of immunisation services in the Brazilian National Immunisation Program.

Authors:  Eliane Matos dos Santos; Gloria Regina da Silva e Sá; Marilda Mendonça Siqueira; Reinaldo de Menezes Martins; Luiz Antonio Bastos Camacho; Vanessa dos Reis von Doellinger; Maria de Lourdes de Sousa Maia
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-05-07       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.